Teva looking for 'further sales'
The leading drugs company Teva has stated that it placed Romania on the top of its agenda in terms of sales within the coming 3 years.
It said it will look to make profits of $60 million (£30.2 million) in the next few years via expansion of its current product portfolio, reports zf.ro.
However, if this fails, it commented, the company will look towards making fresh acquisitions on the domestic market and greenfield investments.
Country manager of Teva Pharmaceuticals Dana Stanciulescu stated that there a number of plans that the company has in place.
"Teva is interested in developing on the domestic market and gaining market share. So far, in 2007, we have launched 20 new products onto the domestic market, however, the bulk of new products will come next year," he commented to the publication.
Recently, Cameron, the oil services provider, recently said that it is looking to invest further on the Romanian market.
< Back to latest news